AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
6.74
+0.02 (0.30%)
Nov 20, 2024, 4:00 PM EST - Market closed
AngioDynamics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AngioDynamics stock have an average target of 12, with a low estimate of 10 and a high estimate of 14. The average target predicts an increase of 78.04% from the current stock price of 6.74.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 4, 2024.
Analyst Ratings
The average analyst rating for AngioDynamics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +107.72% | Oct 4, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +78.04% | Oct 4, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +107.72% | Sep 20, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $13 | Strong Buy | Maintains | $18 → $13 | +92.88% | Jul 17, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +107.72% | Jul 17, 2024 |
Financial Forecast
Revenue This Year
289.54M
from 303.91M
Decreased by -4.73%
Revenue Next Year
311.82M
from 289.54M
Increased by 7.69%
EPS This Year
-0.41
from -4.59
EPS Next Year
-0.24
from -0.41
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 298.4M | 326.1M | 360.4M | |
Avg | 289.5M | 311.8M | 350.1M | |
Low | 277.7M | 294.5M | 336.4M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | -1.8% | 12.6% | 15.6% | |
Avg | -4.7% | 7.7% | 12.3% | |
Low | -8.6% | 1.7% | 7.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | -0.42 | -0.24 | 0.15 | |
Avg | -0.41 | -0.24 | 0.14 | |
Low | -0.39 | -0.25 | 0.14 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | - | - | - | |
Avg | - | - | - | |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.